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Congenitally athymic (nude) female mice show severe ovarian dysgenesis after puberty, which
seems to be consequential to a number of neuroendocrine derangements described in these
mutants. Thus, considerable evidence suggests that thymulin, a thymic peptide, may be involved
in thymus-pituitary communication. Inorder toclarify the relevanceof thymulin for thematuration
of the female reproductive system, we assessed at hypothalamic, pituitary, ovarian, and uterine
level thepreventive actionofneonatal thymulingene therapy (NTGT)on the changes that typically
occur after puberty in congenitally athymic female mice. We injected (im) an adenoviral vector
harboring a synthetic DNA sequence encoding a biologically active analog of thymulin, methio-
nine-serum thymic factor, in newborn nude mice (which are thymulin deficient) and killed the
animals at 70–71 d of age. NTGT in the athymic mice restored the serum thymulin levels. Mor-
phometric analysis revealed that athymic nudes have reducednumbers of brainGnRHneurons and
pituitary gonadotropic cells as compared with heterozygous controls. NTGT prevented these
changes and also rescued the premature ovarian failure phenotype typically observed in athymic
nudemice (marked reduction in thenumber of antral follicles and corpora lutea, increase in atretic
follicles). Serumestrogen, butnotprogesterone, levelswere low inathymicnudes, a reduction that
was partially prevented by NTGT. Little to no morphological changes were observed in the endo-
metriumof femalenudes. Thedelay in theageof vaginal opening that occurs in athymic nudeswas
significantly preventedbyNTGT.Our results suggest that thymulinplays a relevantphysiologic role
in the thymus-hypothalamo-pituitary-gonadal axis. (Endocrinology 153: 3922–3928, 2012)
During perinatal life, the integrity of the thymus is nec-essary for a proper maturation of the pituitary-go-
nadal axis as revealed by the endocrine alterations caused
by neonatal thymectomy or congenital absence of the thy-
mus in mice. In effect, congenitally athymic (nude) female
mice show significantly reduced levels of circulating go-
nadotropins, a fact that seems to be causally related to a
number of reproductive derangements described in these
mutants (1). In homozygous (nu/nu) females, the times of
vaginal opening and first ovulation are delayed (2), fertil-
ity is reduced (3), and follicular atresia is increased, such
that premature ovarian failure results (3, 4). Similar
abnormalities result from neonatal thymectomy in nor-
mal female mice (5, 6). Neonatal thymus grafting pre-
vents the consequences of the lack of thymus in the
above models (2).
Thymulin is a well-characterized thymic factor discov-
ered, purified, and sequenced during the 1970s (7). It con-
sists of a biologically inactive nonapeptide component,
FTS (facteur thymique serique, an acronym for serum thy-
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mus factor in French), coupled in an equimolecular ratio
to the ion zinc (8), which confers biological activity to the
molecule (9).
Thymulin has been shown to stimulate gonadotropin
release from dispersed rat pituitary cells in a dose-related
manner, an effect thatdeclinedwith theageof thepituitary
cell donors (10). The gonadotropin-releasing activity of
thymulin has been also shown in rat pituitary fragments
and in primary rat pituitary cell cultures (11, 12). There is
evidence suggesting that thymulin plays a role in the reg-
ulation of female puberty (13) and that it may exert a
modulatory action on gonadotropin-induced steroido-
genesis in the ovary (14) and testis (15).
We have previously shown that serum thymulin immu-
noneutralization from birth to postnatal day (P)8–P9 in
normal mice induces a significant fall in serum gonado-
tropin levels at puberty. Conversely, in the same study, it
was demonstrated that neonatal thymulin gene therapy
(NTGT) in nude female mice (nude mice have undetect-
able circulating levels of thymulin) elicited long-term resto-
ration of serum thymulin in these mutants. This treat-
ment, which used a synthetic gene encoding the FTS
analog methionine-FTS (metFTS) (59-ATGCAGGC-
CAAGTCGCAGGGGGGGTCG-AACTAGTAG-39), was
able to prevent the deficits in serum LH and FSH that typi-
cally appear in adult female nudes (16). In the present study,
weassessed, at hypothalamic, pituitary, ovarian, anduterine
level, the preventive action of NTGT on the changes that
typically occur after puberty in congenitally athymic female
mice.
Materials and Methods
Animals and experimental procedures
The offspring of NIH homozygous (nu/nu) nude male and
heterozygous (nu/1) female mice were used. The parent mice
were purchased from the Animal Core Facility of the Ezeiza
Atomic Center (Ezeiza, Argentina). All miceweremaintained on
a g-irradiate chow diet and sterilized water. Animals had free
access to food andwater andwere kept at 22Cwith a 12-h light,
12-h dark cycle. All animal experimentswere done following the
Animal Welfare Guidelines of the National Institutes of Health
(Instituto de Investigaciones Bioquímicas de La Plata’s Animal
Welfare Assurance No. A5647-01).
On P1, each experimental pup (both nu/nu and nu/1) re-
ceived a single bilateral im (hindlegs) injection of 108 plaque
forming units recombinant adenoviral (RAd)-FTS or RAd-green
fluorescent protein (GFP) (a control vector; see below) in 10 ml
of vehicle (5 ml per side). On P13, three mice from each group
were bled for thymulin determination. Beginning on P 22, ani-
mals were daily checked for vaginal opening.
On P70–P71, mice were bled and immediately killed by cer-
vical dislocation or perfusion with fixative as appropriate. The
brain, pituitary gland, ovaries, and uterus were removed and
stored in fixative solution for morphologic assessment.
Adenoviral vectors
Recombinant adenoviral-FTS
A DNA sequence (59-ATGCAGGCCAAGTCG-
CAGGGGGGGTCGAACTAGT AG-39) coding for the biolog-
ically active thymulin analog metFTS, here referred to as syn-
thetic gene for thymulin, was constructed as previously reported
(17). A RAd vector harboring the synthetic gene for thymulin
was constructed by a variant of the two-plasmid method (18)
employing the AdMax plasmid kit (Microbix, Toronto, Can-
ada). This kit uses a shuttle plasmid (pDC515) containing a FRT
recognition site for the yeast FLP recombinase. This cassette is
flanked by sequences of the adenovirus type 5 (Ad5) E1 region.
The second plasmid of the kit, the genomic plasmid pBHGfrt-
(del)E1,3 FLP, consists of the entire genome of Ad5, containing
deletions in the regions E1 and E3. Upstream the E1 deletion, the
genomic plasmid contains an expression cassette for the gene of
yeast FLP recombinase, and immediately downstream the E1
deletion, a FRT recognition site has been inserted. Once the thy-
mulin synthetic genewas inserted into the shuttle, both plasmids
were cotransfected intoHEK293 cells. In cotransfectedHEK293
cells, FLP recombinase is readily expressed and efficiently cata-
lyzes the site-directed recombinationof the expression cassette of
pDC515-metFTS into the left endofpBHGfrt(del)E1,3FLP, thus
generating the genome of the desiredRAd vector, RAd-FTS (Fig.
1A). The newly generated RAd was rescued from HEK293 cell
lysates and plaque purified. It was further purified by ultracen-
trifugation in CsCl gradient and titrated by a serial dilution
plaque assay.
Recombinant adenoviral-GFP
An adenoviral vector termed RAd-GFP was also constructed
following the general procedures outlined above andwas used as
a control vector (Fig. 1B). The vector harbors a DNA sequence
encoding a chimeric variant of the Aequorea victoria-enhanced
GFP fused toHSV-1 thymidinekinase (GFP/TK), akindgift from
Jacques Galipeau (McGill University, Montreal, Canada).
FIG. 1. Recombinant adenovectors expressing metFTS (thymulin) and
GFP. A, A DNA sequence coding for the thymulin analog metFTS was
cloned in a first generation adenovector backbone, thus generating
RAd-FTS. B, A DNA sequence encoding a chimeric variant of enhanced
GFP (GFP/TK) was cloned in an adenovector thus generating RAd-GFP,
a control vector. PmCMV, Mouse cytomegalovirus promoter; T7,
phage T7 promoter primer binding site; ITR, inverted terminal repeats;
DE1 and DE3, deletions in the Ad5 genome; Sv40pA, simian virus 40
polyadenylation signal; c, packaging signal.
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Hormone assays
Thymulin bioassay
Biologically active thymulin was measured in serum by a ro-
sette bioassay described in detail elsewhere (19). This method is
based on the ability of thymulin to restore the inhibitory effect of
azathioprine on rosette formation in spleen cells from thymec-
tomized mice. The inhibitory activity of samples was compared
with that of a standard curve using synthetic thymulin. Serum
values were expressed as femtograms permilliliter bioactive thy-
mulin. This bioassay has been previously validated against an
ELISA for thymulin (17).
Steroid hormone assays
Serumb-estradiol (E2) andprogesterone (P4) levelsweremea-
sured byRIA using a commercial kit (Coat-A-Count; Diagnostic
Products Corp., Los Angeles, CA).
Histology and immunohistochemistry
Brain GnRH immunofluorescence and morphometry
Animalswereplacedunderdeepanesthesia and intracardially
perfused with cold phosphate-buffered paraformaldehyde 4%
(pH 7.4) fixative. Each brain was removed and serially cut into
30-mm-thick coronal sections on a freezingmicrotome. For each
brain, one out of every four serial sections was selected to obtain
four sets of noncontiguous serial sections spanning the whole
brain. For counting purposes, each set was considered as repre-
sentative of the whole brain taken between coordinates 2.22 up
to22.46 from the bregma (20). For each animal, one set of brain
sections was processed for immunofluorescence using the free
floating technique (21). Briefly, sections were incubated for 45
min with a 1:3000 dilution of anti-GnRHmonoclonal antibody
LHR 13 (Institute for Molecular and Cellular Regulation, Mae-
bashi, Japan), washed twice with PBS, and incubated for 45 min
with a 1:300 dilution of an Alexa Fluor 488 antimouse Fc (In-
vitrogen BA, Buenos Aires, Argentina). Images were captured
using an Olympus DP70 digital camera attached to an Olympus
BX51 microscope (Olympus, Tokyo, Japan) and were analyzed
using the ImagePro Plus version 5.1 image analysis software
(MediaCybernetics, Silver Spring,MA).GnRH immunoreactive
perikarya were counted. The distribution and density of GnRH
fibers were also recorded.
Anterior pituitary immunohistochemistry
Immunohistochemical analysis was used to evaluate the ef-
fects of treatments on the population of luteotrope and follicu-
lotrope cells in pituitary tissue.
Histological and histomorphometric assessment of
ovaries and uterus
Ovaries and uteri were removed, fixed in 4% formaldehyde,
and embedded in paraffin. Serial ovarian and transversal uterine
horn 4-mm-thick sections were stained with hematoxylin and
eosin. Micrographs of ovarian and uterine sections were taken
with a digital camera, and corresponding images were analyzed
using the ImagePro Plus software. The number of antral follicles,
corpora lutea, and atretic follicles per square millimeter was de-
termined using 20 images per animal takenwith a310objective.
The height of the uterine epithelium was assessed counting 100
cells in a total of 10 images per uterus takenwith a340objective.
Statistical analysis
Data are expressed as mean 6 SEM, unless otherwise indi-
cated. Statistical comparisons among experimental groups were
performed by ANOVA followed by the Dunnett test when the
ANOVAwas significant. For serum E2 data, the Tukey test was
used. Differences with a P . 0.05 were considered
nonsignificant.
Results
Restorative effect of RAd-FTS administration on
serum thymulin in nude mice
A single neonatal im injection of RAd-FTS, but not
RAd-GFP (a control vector), increased the circulating lev-
els of biologically active thymulin in both heterozygous
and homozygous nude mice tested at 70–71 d of age (Ta-
ble 1). At P13, the RAd-FTS-treated nu/nu mice achieved
serum thymulin levels only slightly lower than those of
control nu/1 animals, whereas RAd-FTS-treated
heterozygous mice showed thymulin levels comparable
with those of control counterparts.
Preventive action of NTGT on GnRH-producing
neurons and pituitary gonadotrophic cells in nude
mice
Congenital athymia induced a significant (P , 0.05)
reduction in the number of brain GnRH-producing neu-
rons, a phenotype rescued by NTGT (Fig. 2). This pre-
ventive action was clear for GnRH neuron bodies located
mainly in the preoptic and anterior hypothalamic area.
The fiber density of GnRH-producing neurons in the me-
TABLE 1. Serum thymulin (fg/ml) in experimental and control nude mice
Experimental group nu/1 nu/nu
Age (days) RAd-GFP RAd-FTS RAd-GFP RAd-FTS
13 150 6 30 (3)a 171 6 43 (3)a 8 6 1.2 (3) 107 6 21(3)a
70–71 117 6 11 (8)a 427 6 127 (8)a 8.7 6 1.6 (8) 256 6 81 (8)a
Data are expressed as mean 6 SEM. Numbers in parentheses represent the N value per group.
a Significant differences vs. RAd-GFP nu/nu; P , 0.001.
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dian eminence and its vicinity was similar in thymulin
gene-treated athymic animals compared with heterozy-
gous controls (Supplemental Fig. 1, published on The En-
docrine Society’s Journals Online web site at http://en-
do.endojournals.org). NTGTprevented the occurrence of
low numbers of anterior pituitary luteotropic and follicu-
lotropic cells typically observed in adult athymic female
nudes (Supplemental Fig. 2).
NTGT prevents ovarian dysgenesis in nude mice
Heterozygous nudes had normal ovaries showing fol-
licles in all developmental stages aswell as normal corpora
lutea. As expected, control homozygous nude females dis-
played multiple ovarian anomalies, characterized by re-
duced numbers of antral (secondary and tertiary) follicles
(P , 0.01) and corpora lutea (P , 0.001) as well as in-
creased numbers of atretic follicles (P, 0.05), compared
with normal age-matched counterparts (Figs. 3 and 4).
Preovulatory follicles were not observed in athymic con-
trols, but there were numerous follicles displaying devel-
opment of the granulosa cell layer containing a substantial
numberofdead cells.Mostof these follicles lackedoocytes
andwere classified as atretic. Lymphocyte infiltrationwas
observed neither in the ovaries of homozygous nor
heterozygous nudes whether control or RAd-FTS treated
(Fig. 3). NTGT prevented the incidence of ovarian alter-
ations in homozygous nude females (Figs. 3D and 4). The
ovaries of treated nudes showed a number of developing
follicles, corpora lutea, and atretic follicles comparable with
that of control heterozygous nudes. The number of primary
follicleswasunaffectedbyathymiaor thymulingene therapy
(data not shown). Low serum levels of estrogen (P, 0.01)
were observed in control nu/nu females but not in nudes
submitted to NTGT (Fig. 5). P4 levels were not signif-
icantly different in athymic nudes and heterozygous
mice and were not affected by NTGT (Fig. 5).
Effects of thymulin gene therapy on uterine
morphology in nude mice
No inflammatory changes in the uteri of control nude
mice were detected (Supplemental Fig.
3).A trend towarddecreased (P50.09)
epithelial cell height was observed in
the endometrium of homozygous fe-
male nudes, although it was not statis-
tically significant (Supplemental Figs. 3
and 4). The epithelial height of RAd-FTS-
treated athymic nudes was comparable
with that of heterozygous animals.
NTGT and puberty in nude female
mice
As expected, homozygous female
nudes exhibited a significant (P ,
0.001) delay in the age of vaginal open-
ing.NTGTsignificantly (P,0.05) pre-
vented this delay (Fig. 6). Nevertheless,
the age of vaginal opening inRAd-FTS-
treated athymic nudes still showed a
slight delay compared with control
heterozygous mice.
FIG. 3. Effect of thymulin gene therapy on ovarian morphology in nude mice. H&E-stained
sections of ovaries from nu/1 (A) and nu/nu (C) mice treated with the control vector (RAd-
GFP) and nu/1 (B) and nu/nu (D) mice submitted to NTGT. Scale bar, 200 mm.
FIG. 2. GnRH-producing neuron numbers in the brain of control and
experimental hetero and homozygous nude females. GnRH perikarya
were counted in one every four coronal sections of the whole brain,
and the sum of all counted sections per mouse was multiplied by 4
(thus, values represent an estimate of total brain GnRH-producing
neurons). Numbers above columns are in the format (N;CV) and
represent the N value and the coefficient of variation per group,
respectively. Asterisks refer to differences vs. corresponding control
nu/nu; **, P , 0.01; *, P , 0.05.
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Discussion
Thymulin is probably the best characterized of all putative
thymic hormones and seems to play a physiologic role in
thymus-pituitary communication, particularly during
perinatal life (22). Interest in the therapeutic use of thy-
mulin flourished during the 1970s and 1980s, when ef-
forts where almost exclusively focused on using thymulin
(and other thymic peptides) for the treatment of autoim-
mune pathologies as well as cancer (23, 24). Subsequent
studies, most of them carried out during the last 20 yr,
established that thymulin is active on the hypophysis and
the brain. This awareness and the availability of a syn-
thetic gene for thymulin (17) provide new avenues for
functional studies of this metallopeptide in the endocrine
system. The nude female mouse provides a suitable model
of reproductive dysgenesis associated with the absence of
the thymus and was therefore chosen in this study for the
assessment of the physiological relevance of thymulin for
the maturation of the hypothalamo-pituitary-ovarian
axis.
To our knowledge, there is no pre-
vious documentation of the impact of
congenital athymia on the GnRH neu-
ron population in themouse brain.Our
data demonstrate a small (15%) but
significant reduction in the number of
GnRH neurons in athymic females.
This reduction, which was prevented
byNTGT, is likely tobeassociatedwith
a reduced synthesis and secretion of
GnRH into the anterior pituitary portal
system, which in turn could contribute
to the reduced size of the gonadotropic
cell population in the pituitary of nude
females. This is in line with studies re-
porting that injectionof thymulin in the
medial, but not in the anterior hypothalamus, of normal
prepubertal mice (20 d old) reversed the blocking effect of
ether anesthesia on ovulation (25). Although hypotha-
lamic GnRH content in congenitally athymic mice has
been reported to be similar to that of their heterozygous
counterparts (26, 27), athymic nudes (21 d old) failed to
increase their serum LH levels in response to ovariectomy
but did respond to GnRH injection (26), suggesting an
impaired GnRH neuron function in homozygous nude
mice. In previous studies, we demonstrated that in 51- to
52-d-old homozygous nude females, the gonadotropic pi-
tuitary cell population and serum gonadotropin levels are
reduced compared with their heterozygous counterparts
and that these changes were prevented byNTGT (16, 28).
Because thymulin possesses gonadotropin-releasing activ-
ity in vitro (10–12), it is likely that in vivo, the peptide
exerts its stimulatory effect on gonadotropin secretion by
FIG. 4. Histomorphometric assessment of ovaries from control and experimental nude mice.
The number of antral (secondary and tertiary) and atretic follicles (Fol.) as well as corpora
lutea was assessed in the ovaries from nu/1 and nu/nu mice treated with the control vector
(RAd-GFP) and nu/1 and nu/nu mice submitted to NTGT. Asterisks refer to differences vs.
corresponding control nu/nu; ***, P , 0.001; **, P , 0.01; *, P , 0.05. Other details are as
in Fig. 2.
FIG. 5. Serum E2 and P4 levels in control and experimental nude mice.
Steroids were measured in the serum of RAd-GFP- and RAd-FTS-
treated heterozygous and homozygous female nude mice. Asterisks
refer to differences vs. corresponding control nu/1; **, P , 0.01.
Serum E2 levels in metFTS gene-treated nu/nu and control nu/1 mice
did not differ significantly (Tukey test). Other details are as in Fig. 2.
FIG. 6. Effect of thymulin gene therapy on the age of vaginal opening
in nude mice. The age of vaginal opening was assessed in RAd-GFP-
and RAd-FTS-treated heterozygous and homozygous nude mice.
Asterisks refer to differences from corresponding control nu/nu; ***,
P , 0.001; *, P , 0.05. Other details are as in Fig. 2.
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a direct action on the pituitary gland and also by facili-
tating the release of GnRH. Another thymic peptide, thy-
mosin b4, has also been shown to possess LH-releasing
activity (29), which suggests that the thymus gland prob-
ably secretes a number of hypophysiotropic peptides, es-
pecially during perinatal life.
Our results confirm that nude female mice develop se-
vere ovarian dysgenesis and demonstrate that NTGT can
significantly prevent this alteration. Although it is well
established that neonatal thymus grafting can fully pre-
vent the ovarian dysgenesis of nudemice (2), this is, to our
knowledge, the first report showing that such a preventive
effect can be achieved with a single thymic peptide, al-
though in this case, ovarian dysgenesis was largely but not
fully prevented.
In adult homozygous nude female mice, circulating E2
and P4 levels have been reported to be lower than in the
heterozygous counterparts (30),whereas innormal female
mice thymectomized at 10 d of age, serum E2, but not P4,
levels were lower than in intact counterparts (31). In our
control homozygous females, we found a significant re-
duction in serumE2 but no change in P4 levels. NTGTwas
only partially able to prevent the low serumestrogen levels
of homozygous nudes (i.e. serum estrogen levels in the
experimental nu/nu mice were not significantly different
from either the control nu/1 or the control nu/nu groups),
whereas the treatment had no significant effect on serum
P4 levels. Our E2 data are consistent with a study showing
that in congenitally athymic female mice, neonatal graft-
ing of a thymus prevents serum estrogen deficiency (30).
The partial preventive effect of thymulin gene therapy on
serum E2 supports the former notion and suggests an en-
docrine function of the thymus in regards tomaturation of
the reproductive system. It is also important to note that
more than one thymic factor may be necessary to com-
pletely prevent ovarian dysgenesis and deficiencies in ste-
roid production. Although we did not observe significant
changes in the uterine epithelium height of homozygous
nudes, there seems to be a trend toward a reduced height
in control nu/nu females, which would be consistent with
the lowestrogen levels of thesemutants.Althoughan early
study reported that about half of homozygous nude mice
show inflammatory changes in their uteri (31), noneof our
mice showed signs of uterine inflammation. This discrep-
ancy may be due to differences in housing or other breed-
ing conditions in the two studies.
In mice, it has been reported that congenital athymia
and neonatal or infantile thymectomy are associated with
a significant delay in the age of vaginal opening (2, 32), a
well-established sign of the attainment of puberty. Taking
into account that neonatal thymus grafting in nude or
neonatally thymectomizedmice fully prevents the delay in
the age of vaginal opening (2), our results point to thy-
mulin as a thymus effector on the maturation of the re-
productive system in mice.
Taken together, our results strongly suggest that thy-
mulin is a relevant physiologicmediator of the influence of
the thymus on the reproductive system. Immunoneutral-
ization of circulating thymulin levels from P1 to P8 in
normal mice has been shown to be sufficient to cause se-
verely reduced serum gonadotropin levels at 45 d of age
(16),which is consistentwith thewell-established fact that
in mice, the presence of the thymus is critical for neuroen-
docrine maturation only during the first few days of post-
natal life (30, 6).
Thymulin is a highly conserved peptide, whose amino
acid sequence is the same in pigs, mice, and humans, the
only three species in which the sequence has been deter-
mined. This observation and the fact that thymulin affects
the release of all anterior pituitary hormones suggest that
this ancestral peptide may act as a general modulator of
pituitary (and other) hormonal responses to specific re-
leasing or inhibiting factors. This idea is in line with evi-
dence that thymulin modulates GnRH-stimulated gonad-
otropin release (10, 11), TRH-stimulated TSH and
prolactin release (33), and GHRH-stimulated release of
GH (34) in rat pituitary cells. Such a multiple modulatory
effect on hormone secretion has been reported for another
thymic factor (35–38).
The present study complements our previous findings
that NTGT prevents the well-documented deficit of cir-
culating gonadotropins in adult nudes (16) and supports
the hypothesis that thymulin is an important player in the
thymus-reproductive axis. Additionally, our data suggest
that thymulin gene therapymay be an effective strategy to
approach reproductive deficits associated with thymus
dysfunction.
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